Axcella Health Interest Expense | AXLA

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Axcella Health

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.02 M	2.92 M	10 K	3.4 M	2.78 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.4 M	10 K	2.43 M

Quarterly Interest Expense Axcella Health

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-2 K	67 K	-	-43 K	-	-27 K	-	-	-5 K	-	-	-712 K	-708 K	802 K	-	-307 K	-376 K	-542 K	-	-550 K	-515 K	-509 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
802 K	-712 K	-245 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Amarin Corporation plc AMRN	7 K	$ 11.55	-0.2 %	$ 4.79 B	Irlanda
Editas Medicine EDIT	-2.19 M	$ 2.57	0.59 %	$ 228 M	USA
Agios Pharmaceuticals AGIO	1.96 M	$ 29.4	4.0 %	$ 1.7 B	USA
Cue Biopharma CUE	100 K	$ 18.93	5.11 %	$ 1.79 B	USA
Equillium EQ	-76 K	$ 1.54	15.79 %	$ 88.2 M	USA
Black Diamond Therapeutics BDTX	5.78 M	$ 1.73	4.22 %	$ 98.4 M	USA
Pliant Therapeutics PLRX	1.27 M	$ 0.81	-0.12 %	$ 49.7 M	USA
Abeona Therapeutics ABEO	3.74 M	$ 4.18	6.78 %	$ 221 M	USA
Ironwood Pharmaceuticals IRWD	193 K	$ 4.36	8.19 %	$ 706 M	USA
ACADIA Pharmaceuticals ACAD	2.37 M	$ 21.22	-0.09 %	$ 3.57 B	USA
Jazz Pharmaceuticals plc JAZZ	1.44 M	$ 235.01	3.38 %	$ 14.3 B	Irlanda
Atossa Therapeutics ATOS	-6 K	$ 2.14	5.94 %	$ 18.4 M	USA
Liquidia Corporation LQDA	6.27 M	$ 44.53	0.08 %	$ 3.83 B	USA
ADC Therapeutics SA ADCT	22.7 M	$ 1.59	-2.16 %	$ 202 M	Schweiz
Harmony Biosciences Holdings HRMY	-680 K	$ 33.1	1.96 %	$ 1.9 B	USA
Ardelyx ARDX	4.95 M	$ 2.88	-3.85 %	$ 694 M	USA
Akebia Therapeutics AKBA	58 K	$ 0.39	-7.57 %	$ 100 M	USA
Alector ALEC	13.2 M	$ 2.3	9.81 %	$ 237 M	USA
ALX Oncology Holdings ALXO	1.6 M	$ 1.16	0.43 %	$ 62.2 M	USA
Amneal Pharmaceuticals AMRX	16.5 M	$ 20.13	3.5 %	$ 6.31 B	USA
Arbutus Biopharma Corporation ABUS	459 K	$ 3.65	-0.54 %	$ 699 M	Canada
Agenus AGEN	72.4 M	$ 7.13	10.71 %	$ 212 M	USA
AbCellera Biologics ABCL	-2.71 M	$ 11.89	6.83 %	$ 3.55 B	Canada
Artelo Biosciences ARTL	194 K	$ 1.98	-6.62 %	$ 375 K	USA
Immatics N.V. IMTX	946 K	$ 6.36	2.91 %	$ 778 M	Germany
Aptevo Therapeutics APVO	345 K	$ 1.24	-2.36 %	$ 391 K	USA
Aligos Therapeutics ALGS	2.2 M	$ 4.14	-8.2 %	$ 40.9 M	USA
Aclaris Therapeutics ACRS	8.51 M	$ 3.9	8.03 %	$ 478 M	USA
Adaptive Biotechnologies Corporation ADPT	11.8 M	$ 27.98	4.29 %	$ 4.25 B	USA
Cellectar Biosciences CLRB	-426	$ 1.24	7.83 %	$ 3.23 M	USA
Larimar Therapeutics LRMR	1.77 M	$ 2.4	3.23 %	$ 199 M	USA
Capricor Therapeutics CAPR	399 K	$ 8.97	4.3 %	$ 417 M	USA
Amphastar Pharmaceuticals AMPH	23 K	$ 28.5	3.04 %	$ 1.33 B	USA
Aquestive Therapeutics AQST	6.34 M	$ 3.6	-1.64 %	$ 385 M	USA
Jaguar Health JAGX	67 K	$ 0.4	-2.16 %	$ 933 K	USA
Arvinas ARVN	-400 K	$ 6.41	-2.14 %	$ 454 M	USA
Cerus Corporation CERS	3.02 M	$ 2.03	-4.93 %	$ 387 M	USA
Fortress Biotech FBIO	17.6 M	$ 1.86	0.82 %	$ 51.9 M	USA
Inhibrx INBX	-580 K	$ 84.71	5.52 %	$ 3.99 B	USA